Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Parallel Session 3404

Etiology and Management of Neuropsychiatric Complications in Parkinson’s Disease

Saturday, September 17, 2022
15:00 – 17:00


In this session, the faculty will discuss current understanding and recent developments in our understanding of the etiologies of psychiatric complications in Parkinson’s disease, and how it informs clinical management.


Chairs:
Daniel Weintraub, USA
Ruey-Meei Robin Wu, Taiwan

DBS and Psychiatric Symptoms
Haidar Dafsari, Germany

Parkinson’s Disease Psychosis
Javier Pagonabarraga, Spain

Impulse Control Disorders in Parkinson’s Disease
Andrew Evans, Australia

CSPC Liaisons:
Daniel Weintraub, USA
Ruey-Meei Robin Wu, Taiwan

At the conclusion of this session, participants should be better able to:

  1. Describe the psychiatric symptoms related to deep brain stimulation and its underlying pathophysiology in Parkinson’s disease
  2. Summarize the clinical manifestation and etiology of psychosis in Parkinson’s disease; and the management of the psychiatric complications in Parkinson’s disease
  3. Discuss the therapeutic options of impulse control disorder by weighing the risks and benefits of psychiatric approach and Parkinson’s disease therapy

Recommended Audience:
Clinician/General Neurology

Education Level:
Intermediate/Experienced

 

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice